ADAR1 Capital Management’s Wave Life Sciences WVE Stock Holding History

ADAR1 Capital Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$930K	Buy	160,000 +115,100	+256%	+$763K	0.04%	176
2026 Q1	$326K	Buy	+44,900	New	+$585K	0.02%	232
2025 Q4	–	Sell	-119,067	Closed	-$872K	–	297
2025 Q3	$872K	Buy	119,067 +4,253	+4%	+$34.4K	0.08%	107
2025 Q2	$746K	Buy	114,814 +91,714	+397%	+$606K	0.11%	98
2025 Q1	$187K	Buy	23,100 +1,400	+6%	+$15.3K	0.03%	150
2024 Q4	$268K	Buy	+21,700	New	+$290K	0.05%	142
2024 Q3	–	Sell	-76,651	Closed	-$382K	–	347
2024 Q2	$382K	Buy	76,651 +46,651	+156%	+$266K	0.07%	113
2024 Q1	$185K	Buy	+30,000	New	+$150K	0.04%	122

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

ADAR1 Capital Management's WVE Position: Q2 2026 in Review

ADAR1 Capital Management increased its Wave Life Sciences (WVE) stake by 256% in Q2 2026, buying an estimated $763K and bringing the position to 160,000 shares worth $930K. The position accounts for 0.04% of the portfolio, ranked #176.

ADAR1 Capital Management first reported a position in WVE in Q1 2024 and has held it in 8 quarters since. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

ADAR1 Capital Management held 160,000 shares of Wave Life Sciences worth $930K as of Q2 2026.
ADAR1 Capital Management bought 115,100 Wave Life Sciences shares in Q2 2026, an estimated $763K.
Wave Life Sciences made up 0.04% of ADAR1 Capital Management's portfolio in Q2 2026, its #176 holding.
ADAR1 Capital Management first reported a position in Wave Life Sciences in Q1 2024 and has held it in 8 quarters since.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.